AIIC
CLSD

AJU IB Investment Company’s Clearside Biomedical CLSD Stock Holding History

AJU IB Investment Company’s Portfolio CLSD Stock Details CLSD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-19,570
Closed -$1.76M – 9
2021
Q3 		$1.76M Hold
19,570
– – 1.14% 7
2021
Q2 		$1.43M Sell
19,570
-33,334
-63% -$1.55M 0.82% 8
2021
Q1 		$1.96M Hold
52,904
– – 0.74% 8
2020
Q4 		$2.17M Buy
+52,904
New +$1.37M 0.82% 6

Other funds holding CLSD

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
CG
Carmignac Gestion Paris, France $6.51B AUM 19.13% 1-Year Est. Return
ACM
ACT Capital Management Wayne, Pennsylvania $153M AUM
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

AJU IB Investment Company's CLSD Position: Q4 2021 in Review

AJU IB Investment Company sold out of Clearside Biomedical (CLSD) in Q4 2021, closing a stake of 19,570 shares — an estimated $1.76M sold.

AJU IB Investment Company first reported a position in CLSD in Q4 2020 and held it in 4 quarters. The position peaked at $2.17M in Q4 2020. 67 funds tracked by Wall St. Rank hold CLSD as of Q4 2021.

  • AJU IB Investment Company reported no remaining Clearside Biomedical position as of Q4 2021 after selling out during the quarter.
  • AJU IB Investment Company sold 19,570 Clearside Biomedical shares in Q4 2021, an estimated $1.76M.
  • AJU IB Investment Company first reported a position in Clearside Biomedical in Q4 2020 and held it in 4 quarters.
  • AJU IB Investment Company's Clearside Biomedical position peaked at $2.17M in Q4 2020.
  • 67 funds tracked by Wall St. Rank held Clearside Biomedical as of Q4 2021.

Based on AJU IB Investment Company's 13F filing for Q4 2021, filed 9 Feb 2022.